|
Viventia Bio Inc. is a privately held biopharmaceutical company specializing in the discovery and development of a new generation of immunotoxin products offering safer and more beneficial cancer therapies. Viventia is employing its proprietary payload, deBouganin, to create a portfolio of new antibody products directed at proprietary oncology drug targets.
The content of this site is for informational purposes only and is not intended to replace the advice of a health care professional. Please consult your doctor if you have any questions regarding the information contained in this site. Viventia, the Viventia logo, Proxinium, Vicinium, Unlock, Immunomine, Fusogenics, Power + Precision and Armed Antibodies are Trade Marks of Viventia Bio Inc. Copyright 2013 © Viventia Bio Inc. All rights reserved. |
|
|